Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Alopecia in Children: Common and Uncommon Causes and Treatments
Description
The presentation discusses alopecia in children, covering both common and uncommon causes and treatments. A focus on trichotillomania illustrates diagnostic signs, such as broken hairs and behavioral components, with treatment options including behavioral therapy and medications like an acetylcysteine. Other conditions explored include loose anagen syndrome, presenting with fragility of hair, and androgenetic alopecia, which often appears with concurrent acne in teenagers, for which topical and systemic minoxidil, spironolactone, and finasteride can be effective. Additional cases highlight chemotherapy-induced hair loss, which may respond to oral minoxidil after a delay. The presentation emphasizes the importance of thorough examination and potential genetic testing in cases of hypotrichosis and telogen effluvium, the latter linked to stressors and nutrient deficiencies. An algorithm for treating alopecia areata using trichoscopy and understanding immunological factors concludes the session, underscoring diverse pediatric treatment options from topical steroids to JAK inhibitors. The importance of shared decision-making with families is also highlighted.
View moreConclusions
- Trichotillomania can often be misdiagnosed as alopecia areata due to overlapping symptoms, emphasizing the importance of a thorough patient history.
- Behavioral interventions, including habit reversal therapy and N-acetylcysteine, show promise in treating trichotillomania in children.
- Loose Anagen Syndrome is characterized by fragile hair that is prone to breakage and usually improves with age with gentle styling advised.
- Androgenetic alopecia is the primary cause of hair loss in adolescents, presenting with progressive thinning often accompanied by acne and hirsutism.
- Topical and oral minoxidil have been found safe and effective for managing pediatric androgenetic alopecia with a good treatment response rate.
- Genetic testing may be beneficial for diagnosing specific hair loss disorders, particularly when accompanying systemic symptoms are absent.
- Alopecia areata management can be guided by trichoscopy findings, indicating active versus regrowing stages of hair loss and aiding in treatment decisions.
- Telogen effluvium is often a result of stress or nutritional deficiencies and typically resolves with addressing the underlying trigger.
- Emerging therapies, including JAK inhibitors, show promise for severe cases of alopecia areata in adolescents, but require careful monitoring due to potential side effects.
- Parli et al. 2022 Ann Pharmacother 1-8
- Pediatr Dermatol. 2025 Jan 16. doi: 10.1111/pde.15852
- Sinclair BJD (2021) 184, 954
- Oberlin Pediatr Derm 2018,35:388
- J Am Acad Dermatol. 2025 Feb 5:S0190-9622(25)00192-6
- Gomez et al. JDDG ., 2023, Vol.21(1), p.19-25
- Craiglow et al. JAAD 2021 V84(6)
- Bertolini et al. PIOS One 2014;9(5)
- Pham et al. JDD 2022;21(10)
- Waskiel-Burnet et al. J Cosm Derm 202;19(3)
- Wyrwich et al. BJD 2020; 183(4)
- Guttman-Yassky et al. Allergy 2021
- Hordinsky M, et al. Pediatr Dermatol. 2023
- Asfour et al. BJD 2023 , 189(2)
- Castelo. JAAD 2017 76(4)
- Moussa et al, JAAD 2023 88(5)
- Kibbie et al Ped Derm 2021 00(1)